Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.63B P/E - EPS this Y 15.40% Ern Qtrly Grth -
Income -150.22M Forward P/E -11.59 EPS next Y -19.00% 50D Avg Chg -2.00%
Sales 8.3M PEG - EPS past 5Y - 200D Avg Chg -9.00%
Dividend N/A Price/Book 5.37 EPS next 5Y - 52W High Chg -29.00%
Recommedations 1.80 Quick Ratio 29.06 Shares Outstanding 66.29M 52W Low Chg 27.00%
Insider Own 0.30% ROA -17.83% Shares Float 66.10M Beta 1.56
Inst Own 107.22% ROE -27.53% Shares Shorted/Prior 8.41M/8.66M Price 34.43
Gross Margin - Profit Margin - Avg. Volume 445,538 Target Price 67.11
Oper. Margin -1,854.16% Earnings Date Oct 31 Volume 310,948 Change -0.95%
About Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

Celldex Therapeutics, Inc. News
11/20/24 Celldex Announces First Patient Dosed in Phase 1 Healthy Volunteer Study of CDX-622, a Bispecific Antibody, for the Treatment of Inflammatory Diseases
11/11/24 Celldex Therapeutics to Present at Upcoming Investor Conferences
11/08/24 Celldex Therapeutics Third Quarter 2024 Earnings: Beats Expectations
11/06/24 Celldex Therapeutics (CLDX) Reports Q3 Loss, Tops Revenue Estimates
11/06/24 Celldex: Q3 Earnings Snapshot
11/06/24 Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/29/24 Celldex selloff creates buying opportunity, says Guggenheim
10/28/24 Celldex Therapeutics (NASDAQ:CLDX) pulls back 6.1% this week, but still delivers shareholders fantastic 57% CAGR over 5 years
10/26/24 Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
10/25/24 Celldex Announces Upcoming Late Breaking Oral Presentation of 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria at ACAAI 2024
10/23/24 Celldex Therapeutics (CLDX): A Top Small-Cap Growth Stock with Promising Clinical Results
10/15/24 Celldex Therapeutics, Inc. (CLDX): Hedge Funds’ Hidden Gem in Small-Cap Stocks
09/26/24 CLDX Stock Down Despite Upbeat Long-Term Data From Urticaria Study
09/25/24 Celldex Therapeutics Presents Landmark 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV 2024
09/16/24 Celldex Announces Upcoming Late Breaking Oral Presentation of 52 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EADV Congress 2024
09/14/24 Celldex Therapeutics, Inc. (CLDX): Short Seller Sentiment is Bearish on This Cancer Stock
08/10/24 Celldex Therapeutics Second Quarter 2024 Earnings: Beats Expectations
08/08/24 Celldex Therapeutics (CLDX) Reports Q2 Loss, Tops Revenue Estimates
08/08/24 Celldex: Q2 Earnings Snapshot
08/08/24 Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update
CLDX Chatroom

User Image free2dream Posted - 19 hours ago

$CLDX hey assholes ! $INCY gave up , CLDX will get this $5B BO !!!

User Image free2dream Posted - 20 hours ago

$CLDX celldex will win this game !

User Image Wolfofwannabe Posted - 1 day ago

$CLDX Added a few more this morning 🤞

User Image Steve1545 Posted - 1 day ago

$CLDX still

User Image Steve1545 Posted - 2 days ago

$CLDX

User Image lucabrix Posted - 2 days ago

$CLDX Certain ugly evil crows should sometimes have their tongues dry up!

User Image FactsPlease99 Posted - 2 days ago

$CLDX this stock was $22 back in 2021... look at that sell volume. Dont think I have seen that much dumping in a very long time. Buckle up bucka- roos! lol

User Image lucabrix Posted - 2 days ago

$CLDX Finviz today puts Inst Own at 107% +1%

User Image lucabrix Posted - 3 days ago

$CLDX Green close chase away all the ugly black crows

User Image FactsPlease99 Posted - 3 days ago

$CLDX NEW 52 week low! Like I predicted

User Image FactsPlease99 Posted - 3 days ago

$CLDX

User Image FactsPlease99 Posted - 3 days ago

$CLDX Right at 52 week low. If this does not hold then looks like teens is possible. $19 -$20

User Image GeorgiaJean Posted - 3 days ago

$CLDX What is the business model here? How have they managed to stay operational? (Besides ongoing Reverse splits) They employ a lot of people. Do those people show up to work everyday & wonder: “will I have my job in 24mos?” I’m not a troll, I’m intrigued by 110% institutional ownership of a small cap bio like this. Its an unusual dev bio.

User Image FactsPlease99 Posted - 5 days ago

$CLDX Well I had a good day😂 Portfolio was up nice with RKLB TSLA and PLTR!! Up 3k on a day like this I very good

User Image lucabrix Posted - 5 days ago

$CLDX God help me! Is this the Trump Golden Age??

User Image free2dream Posted - 5 days ago

$XBI RFK jr has ZERO qualifications to run HHS nor FDA. You morons have to wake the fuck up ! $LABU $MRNA $SRPT $CLDX

User Image Vonheimler67 Posted - 5 days ago

$CLDX lets drop this thing back to .19

User Image Steve1545 Posted - 5 days ago

$CLDX adding mo. 3,422 long

User Image FactsPlease99 Posted - 5 days ago

$CLDX $22? 😳

User Image FactsPlease99 Posted - 6 days ago

$CLDX $MRNA $SRPT $XBI Actually you bigger idiot if you think he won’t be approved. Trump wants him and with majority of senate and house he will be approved and I am thrilled

User Image free2dream Posted - 6 days ago

$XBI amazing buying opportunity! You must be crazy to think that JFK would ever be approved ! Qualified people only qualify ! Last thing you want idiots to be in charge of science ! $SRPT $MRNA $CLDX

User Image Steve1545 Posted - 1 week ago

$CLDX adding here

User Image FactsPlease99 Posted - 1 week ago

$CLDX red😂😂😂

User Image CEOBuysDisclosures Posted - 1 week ago

$CLDX CEO purchased 11,500 shares at $26.82 for a total of $308,430. Marucci Anthony S now owns 40,284 shares. https://ceo-buys.com

User Image lucabrix Posted - 1 week ago

$CLDX Every now and then shows to be alive, IMO 26 was a good entry

User Image Steve1545 Posted - 1 week ago

$CLDX looks like we got a bidder here

User Image Steve1545 Posted - 1 week ago

$CLDX

User Image free2dream Posted - 1 week ago

$CLDX wake the fuck up celldex !

User Image lucabrix Posted - 1 week ago

$CLDX Cant believe! My little bios are getting hot: SYRS OVID ZYME on the run, CPIX and ZNTL will follow and this stuck at the pole and Pantginis says 80$ TP

User Image FactsPlease99 Posted - 1 week ago

$CLDX

Analyst Ratings
Wells Fargo Equal-Weight Aug 12, 24
HC Wainwright & Co. Buy Aug 12, 24
Cantor Fitzgerald Overweight Jul 30, 24
HC Wainwright & Co. Buy Jul 30, 24
HC Wainwright & Co. Buy Jul 16, 24
Cantor Fitzgerald Overweight Jun 18, 24
Wolfe Research Outperform Jun 11, 24
HC Wainwright & Co. Buy Jun 3, 24
HC Wainwright & Co. Buy May 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Young Diane C. SVP, CHIEF MEDICAL O.. SVP, CHIEF MEDICAL OFFICER Aug 17 Option 6.55 64,000 419,200 47,115 08/19/22
Young Diane C. SVP, CHIEF MEDICAL O.. SVP, CHIEF MEDICAL OFFICER Aug 17 Sell 37.3 19,000 708,700 2,115 08/19/22